Skip to main content

Global Demand for Phenylbutazone Market to Incur Considerable Upsurge During 2025

Phenylbutazone is a nonsteroidal anti-inflammatory drug (NSAID) for the short-term treatment of fever and pain in animals. In the UK and the U.S., it is no longer approved for human use, as it can cause severe adverse effects such as aplastic anemia and suppression of white blood cell production. Phenylbutazone was originally used in humans for the treatment of gout and rheumatoid arthritis in 1949. Phenylbutazone is commonly used in horses for the following purposes: Antipyresis and Analgesia. Phenylbutazone is used for pain relief from musculoskeletal disorders including overuse injuries, sprains, tendinitis, arthralgias, laminitis and arthritis and relief from infection. Phenylbutazone acts directly on musculoskeletal tissue to control inflammation, thereby alleviating pain, and restoring range of motion. Phenylbutazone can be administered intravenously or orally (via powder, paste or feed-in). Phenylbutazone should not be injected in any place other than a vein and administered intramuscularly. Edema and tissue damage may also occur if the drug is injected repetitively into the same vein. Side effects of phenylbutazone include blood dyscrasia, GI ulcers, oral lesions, kidney damage and internal hemorrhage. Phenylbutazone should not be used in combination with vitamin K antagonists such as warfarin as it amplifies the anticoagulant effect of these drugs. Phenylbutazone displaces warfarin from toxic blood levels and plasma binding sites leading to haemorrhage.
Request For Report Sample@ https://www.persistencemarketresearch.com/samples/20644 
The growth in end user industries is expected to increase demand for phenylbutazone.  The growth in veterinary medicine industry is expected to increase consumption of phenylbutazone. In addition, rising demand for non steroidal anti-inflammatory drugs from emerging economies of Asia Pacific and Latin America is expected to boost demand for phenylbutazone.  However, availability of substitutes and government regulations could hamper the growth of this market. Harpagophytum can replace phenylbutazone for treatment of fever and pain in horses.
Asia Pacific is expected to be the largest consumer of phenylbutazone followed by North America and Europe. China and India are the major consumers of phenylbutazone in Asia Pacific due to presence of established end user industries.  Phenylbutazone manufacturers are shifting their base to emerging economies of Asia Pacific due to availability of government subsidies, land and cheap labor. Mongolia, Republic of Korea, Australia and New Zealand are expected to be other major consumers of phenylbutazone in Asia Pacific. North America and Europe are expected to experience moderate to high growth. In addition, demand for phenylbutazone is expected to increase in emerging economies of Latin America due to increasing demand for veterinary drugs. Argentina, Brazil, Colombia and Peru are major consumers of phenylbutazone in Latin America.  
Request For Report Table of Content (TOC): https://www.persistencemarketresearch.com/toc/20644 
The market is dominated by large and medium chemical and pharmaceutical corporations. Some of the key players in this market are Santa Cruz Biotechnology, Inc. (U.S.), Hangzhou Hyper Chemicals Limited (China), Baoji Guokang Bio-Technology Co., Ltd.(China), Wuhan Yitongtai Science and Technology Co., Ltd. (China), Afine Chemicals Limited (china), Shanghai Win-Win Biochemical Co., Ltd. (china), Shaanxi TOP Pharm Chemical Co., Ltd.(China), Hangzhou Hyper Chemicals Limited (China),  Hangzhou Ruijiang Chemical Co., Ltd. (China), Dalian Launcher Fine Chemical Co., Ltd.(China), Croma Life Science Pvt. Ltd (India), Swati Chemicals (India), Suchem Laboratories (India), Uni-med India (India), Afton Pharma (India) and Hefei TNJ Chemical Industry Co., Ltd. (China) among others. Companies are using strategic acquisitions and mergers to remain competitive in the market. In addition, companies are increasing their presence in emerging economies of Latin America and Europe to increase their market presence. 

Comments

Post a Comment

Popular posts from this blog

Collaborative Robot (Cobot) Market Insights Deep Analysis 2022-2030

  With the advancements in technology, robotics is becoming available at a price that suits the pockets of even smaller as well as bigger companies. All thanks to the development of low-cost components, which have paved way for the   upsurge of the collaborative robots or cobots  .Collaborative robots are intended to collaborate with humans at work sites, and hence making automation a trouble-free job for businesses of all sizes. By now, cobots have been seen as a game-changer for a wide variety of applications. W hy cobots over traditional robots? The new robotics technology is outdoing the weighty, daunting robots usually locked in the cages for security reasons. Now, it’s time to make use of cobots in those heavy industrial tasks! These robots are quite affordable, safe, and flexible to deploy. They are programmed to work in collaboration with humans and not under humans—unlike traditional robots. With these advanced-automated robots, you can forget the cages and make ...
Post a Comment
Read more

Intraoperative Neuromonitoring Market Revenue to Record Stellar Growth Rate

  According to  Intraoperative Neuromonitoring Market   Analysis by Research Dive, the global market forecast will be   $3,413.0 million   by the end of 2026 , at a   4.5% CAGR , growing from   $2,400.0 million in the end of 2018 . Intraoperative Neuromonitoring Market Drivers: Growing aged populace globally, along with increasing occurrence of chronic illnesses, are the major driving aspects for the intraoperative neuromonitoring market growth. Furthermore, intraoperative monitoring is an important process that assists in risk management throughout complex surgeries. This factor is projected to propel the market size in the coming years. Furthermore, rising trend of medical tourism along with growing investments for healthcare infrastructure in developing economies are projected to create significant revenue generating opportunities in the global market. Nevertheless, shortage of trained workforce for the control and maintenance of intraoperative neur...
Post a Comment
Read more

2-ethylhexyl Caprate Market to Incur Meteoric Growth During 2018-2026

Introduction: 2-Ethylhexyl Caprate Market 2-ethylhexyl caprate , also known as 2-ethylhexyl decanoate, is an organic chemical compound with the molecular formula C18H32O2. In the manufacturing of 2-ethylhexyl caprate, ethyl reacts with hexyl in the presence of caproic acid as a catalyst to form 2-ethylhexyl caproic acid, which on further treatment with esterification process forms a mixture of 2-ethylhexyl caprate crude. This mixture of 2-ethylhexyl caprate crude is distilled to obtain pure 2-ethylhexyl caprate. 2-ethylhexyl caprate finds several applications in chemical, pharmaceutical and textile industries as a reagent, catalyst and excipient. Along with this, 2-ethylhexyl caprate is used in the manufacturing of elastomers and coatings. On the basis of safety, 2-ethylhexyl caprate is the least harmful in the available caprate group and has low vapor pressure, which can reduce hazards while handling as compared to other caprates, such as ethylhexyl palmitate and oth...
Post a Comment
Read more